Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors.
Sechenov Institute of Evolution, Physiology, and Biochemistry, Russian Academy of Sciences, pr. Morisa Toreza 44, St. Petersburg, 194223 Russia.
E V
EV
Rozengart
D000470:Alkaloids / Q000737:chemistry*; D000691:Anabasine / Q000737:chemistry*; D000818:Animals; D001392:Azocines / Q000737:chemistry*; D002091:Butyrylcholinesterase / Q000737:chemistry; D002800:Cholinesterase Inhibitors / Q000737:chemistry*; D002802:Cholinesterases / Q000737:chemistry*; D003998:Dicarboxylic Acids / Q000737:chemistry*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors; D004795:Enzyme Stability; D004912:Erythrocytes / Q000737:chemistry / Q000201:enzymology; D006736:Horses; D006801:Humans; D011807:Quinolizines / Q000737:chemistry*; D013034:Sparteine / Q000031:analogs & derivatives* / Q000737:chemistry*; D013237:Stereoisomerism; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D000691:Anabasine; D001392:Azocines; D002091:Butyrylcholinesterase; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases; D003998:Dicarboxylic Acids; D004791:Enzyme Inhibitors; D011807:Quinolizines; D013034:Sparteine; C015971:lupinine; D000093843:Quinolizidine Alkaloids; C004712:cytisine